(Q37112088)

18 August 2017

Recurrent inactivating RASA2 mutations in melanoma (English)

1 reference

18 August 2017

22

Shifra Ben-Dor

0 references

Sivasish Sindiri

Sivasish Sindiri

11

0 references

Peter Johansson

Peter Johansson

14

0 references

Antonia Pritchard

Antonia L Pritchard

15

0 references

Igor Ulitsky

Igor Ulitsky

24

0 references

Masha Niv

Masha Y Niv

23

0 references

Yardena Samuels

Yardena Samuels

28

0 references

Graham J Mann

Graham J Mann

25

0 references

Richard Scolyer

Richard A Scolyer

26

0 references

Nicola J Waddell

16

Nicola Waddell

1 reference

18 August 2017

Ron Rotkopf

12

0 references

Antonella Di Pizio

Antonella Di Pizio

9

0 references

Steven Rosenberg

20

Steven A Rosenberg

1 reference

18 August 2017

7

James S Wilmott

1 reference

18 August 2017

13

Ken Dutton-Regester

1 reference

18 August 2017

5

Jason Madore

1 reference

18 August 2017

Rand Arafeh

1

1 reference

18 August 2017

Nouar Qutob

2

1 reference

18 August 2017

Rafi Emmanuel

3

1 reference

18 August 2017

Alona Keren-Paz

4

1 reference

18 August 2017

Abdel Elkahloun

6

1 reference

18 August 2017

Jared J Gartner

8

1 reference

18 August 2017

Sabina Winograd-Katz

10

1 reference

18 August 2017

Victoria K Hill

17

1 reference

18 August 2017

Jimmy C Lin

18

1 reference

18 August 2017

Yael Hevroni

19

1 reference

18 August 2017

Javed Khan

21

1 reference

18 August 2017

Shifra Ben-Dor

22

1 reference

18 August 2017

Nicholas K Hayward

27

1 reference

18 August 2017

language of work or name

English

0 references

publication date

26 October 2015

1 reference

18 August 2017

1 reference

18 August 2017

47

1 reference

18 August 2017

12

1 reference

18 August 2017

1408-1410

1 reference

https://scigraph.springernature.com/pub.10.1038/ng.3427

18 August 2017

0 references

cites work

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

A highly recurrent RPS27 5'UTR mutation in melanoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Integration of protein abundance and structure data reveals competition in the ErbB signaling network

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

14 September 2017

Cancer genome landscapes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Cancer statistics for Hispanics/Latinos, 2012.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

A landscape of driver mutations in melanoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Exome sequencing identifies GRIN2A as frequently mutated in melanoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Cell signaling by receptor tyrosine kinases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

The consensus coding sequences of human breast and colorectal cancers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

The MAPK signalling pathways and colorectal cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

p120 Ras GTPase-activating protein interacts with Ras-GTP through specific conserved residues

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

14 September 2017

p53: puzzle and paradigm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4954601

3 September 2018

Identifiers

DOI

10.1038/NG.3427

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

26502337

1 reference